HealthTech startup HealthPresso is all set to raise a $1 million pre-series A funding round, instrumental in the platform’s initial growth phase, according to a company statement.
The statement said that the investor community has shown substantial interest in HealthPresso, recognising the potential of its custom AI-engine (HumetaTM) and extensive distribution network. This infusion of capital will accelerate the growth trajectory, enabling the scaling of operations and enhancement of service offerings.
Daleep Manhas, Co-Founder and CEO and Dr Swadeep Srivastava, Founder and Chief Belief Officer, jointly said in the statement, “The investor community has shown substantial interest in HealthPresso, recognising the potential of its custom AI-engine (HumetaTM) and extensive distribution network. This infusion of capital will accelerate the growth trajectory, enabling the scaling of operations and enhancement of service offerings.”
HealthPresso is wielding the power of AI to transform the industry. The platform has been adopted by a new-age HealthTech company for exclusive communication needs and to enhance its communication strategies.